About
Vaporox Inc. is a medical device company based in Colorado, with locations in Denver and Centennial. Founded between 2016 and 2019, the company specializes in advanced wound care technology. Its primary product, Vaporous Hyperoxia Therapy (VHT™), is a patented system that delivers vaporous oxygen to wounds, promoting faster healing. This FDA 510(k)-cleared therapy is effective for various skin wounds, particularly diabetic foot ulcers, and has shown success in healing over 80% of resistant cases. Vaporox serves the healthcare sector, focusing on patients with chronic wounds. Its technology is designed for hospitals, wound care clinics, and healthcare providers who seek innovative and cost-effective solutions for wound management. The leadership team, including CEO Alan Sage and Chief Product Officer Loren Hutchins, brings extensive experience in medical device development and commercialization. Vaporox is committed to improving patient outcomes in wound care through its advanced therapeutic solutions.
Technologies
Keywords
Company Information
-
Employees 22
-
Founded 2016
-
Annual Revenue $2300000
-
Total Funding $2175489
Location
Denver, Colorado, United States